NKGen Biotech
About:
NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.
Website: https://nkgenbiotech.com/
Twitter/X: nkgenbiotech
Top Investors: Gaingels
Description:
NKGen Biotech, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic, and CAR-NK Natural Killer (NK) cell therapeutics. Leveraging proprietary cell expansion and activation technologies along with cutting-edge cell manufacturing expertise, NKGen Biotech has the ability to infinitely expand natural killer cells while significantly enhancing cytotoxicity.
$16M
$1M to $10M
Santa Ana, California, United States
2017-01-01
info(AT)nkgenbiotech.com
Sangwoo Park
51-100
2024-04-11
Public
© 2025 bioDAO.ai